Psychiatry AtlasMedication guide · United States

Tricyclic antidepressant; separate low-dose sleep medicine

Doxepin (Sinequan, Silenor)

Generic name
doxepin hydrochloride
Brand names
Sinequan; Silenor
Medication class
Tricyclic antidepressant; separate low-dose sleep medicine
Forms covered
Doxepin hydrochloride antidepressant capsules; Silenor 3 mg and 6 mg tablets

Article updated: 2026-10-30 · Sources last checked: 2026-11-05

Medication Safety Alerts

Look-alike / sound-alike name

  • Sinequan can be confused with saquinavir. Sinequan is a historical US brand name for this medication.
  • Sinequan can be confused with Seroquel. Sinequan is a historical US brand name for this medication.
  • Sinequan can be confused with Singulair. Sinequan is a historical US brand name for this medication.
Show more (2)
  • Sinequan can be confused with Zeniquin (veterinary medication). Sinequan is a historical US brand name for this medication. Zeniquin is a veterinary medication.
  • Sinequan can be confused with Zonegran. Sinequan is a historical US brand name for this medication.

FDA Boxed Warning

Antidepressant capsules; not low-dose Silenor tablets.

Doxepin antidepressant capsules carry a boxed warning for increased suicidal thoughts and behaviors in children and young adults; monitor all patients for worsening symptoms. Low-dose Silenor tablets do not carry this boxed warning, although their label retains depression and suicidality precautions.

Doxepin capsules treat major depression in adults. Much lower-dose Silenor tablets treat difficulty staying asleep; the products have different instructions and warnings.

Sinequan (historical brand).

What to expect: For depression, fuller benefit may take several weeks or longer; early sleepiness is not the same as an antidepressant response.

Warning signs · Medicine forms
Sources last checked:
2026-11-05

What is this medicine used for?

FDA-approved uses

  • Major depressive disorder — Adults. Current capsule indication; Silenor doses do not treat MDD.Doxepin hydrochloride antidepressant capsules.
  • Insomnia with difficulty maintaining sleep — Adults. Maximum 6 mg/day; product-specific administration.Silenor 3 mg and 6 mg tablets.

What should I expect?

For depression, fuller benefit may take several weeks or longer; early sleepiness is not the same as an antidepressant response. Follow mood and daily functioning over time.

Low-dose Silenor is intended to help maintain sleep on nights it is taken. If insomnia persists after 7–10 days or worsens, contact the prescriber rather than borrowing an antidepressant dose.

How do I take it safely?

Follow the capsule schedule prescribed for depression. For Silenor, take within 30 minutes of bedtime and not within three hours of a meal, with time for a full night of sleep. Do not divide capsule contents to imitate a low-dose sleep tablet.

Do not combine products without explicit review. MAO inhibitors, including linezolid and intravenous methylene blue, require avoidance and planned waiting periods. Capsules must be separated from a psychiatric MAOI by at least 14 days in either direction.

The capsule is contraindicated with glaucoma or current/past urinary retention; Silenor specifically prohibits untreated narrow-angle glaucoma and severe urinary retention. Allergy also rules out use. Discuss heart disease, seizures, bipolar disorder, liver disease and falls.

Avoid alcohol and unreviewed sedatives or antihistamines. Enzyme-blocking medicines can require lower capsule doses and level monitoring. Cimetidine limits Silenor to 3 mg daily. Liver impairment and older age also affect Silenor dosing.

Monitor mood, daytime alertness, bowel and bladder symptoms and sleep behavior. Severe sleep apnea makes Silenor ordinarily unsuitable. Contact the prescriber immediately for activities while not fully awake.

Capsules should be reduced gradually. Take a missed capsule dose when remembered unless the next is close, then skip; never double. A missed Silenor bedtime dose should not be taken during the day; brief studies did not show its own withdrawal syndrome.

Discuss pregnancy. Both selected labels advise against breastfeeding because doxepin and its active breakdown product enter milk and may seriously sedate an infant or suppress breathing. Pediatric use is not established.

What side effects should I know about?

  • Capsules: sedation, dry mouth, constipation and dizziness. Silenor: sleepiness/sedation and nausea.

Tell your prescriber about effects that are persistent, troublesome, or interfere with daily life.

Which warning signs need help?

  • FDA boxed warning for antidepressant capsules: antidepressants can increase suicidal thoughts and behaviors in children, adolescents and young adults in short-term studies. Monitor everyone for worsening mood or unusual behavior, especially during the first few months and after a dose change. Silenor does not carry this boxed warning, but its label also warns about worsening depression and suicidality.
  • New suicidal thoughts or a severe mood or behavior change needs immediate clinical contact; get emergency help if someone cannot stay safe.
  • Get urgent medical care for fever with confusion or agitation, heavy sweating, diarrhea and stiff or twitching muscles. This combination may be serotonin syndrome, a potentially life-threatening reaction.
  • Contact the prescriber promptly for unusually high energy, very little need for sleep or risky behavior; these can be signs of mania.
  • Contact the prescriber immediately for sleep-driving or other activities while not fully awake during Silenor treatment.
  • A painful red eye with vision changes, severe confusion, inability to pass urine or fainting needs urgent assessment.
  • Overdose can cause fatal heart toxicity, seizures or coma, including with a medicine usually prescribed for sleep. Seek emergency advice immediately.
  • Get emergency help for trouble breathing, swelling of the tongue or throat, collapse, a seizure or inability to wake. Suspected overdose needs immediate poison-center or emergency advice; do not wait for symptoms.

What else should I know to stay safe?

  • Do not use with an MAOI or after doxepin allergy; capsules require at least 14 days in either MAOI switching direction. Linezolid and intravenous methylene blue also require avoidance. Capsules prohibit glaucoma or current/past urinary retention; Silenor specifically prohibits untreated narrow-angle glaucoma and severe urinary retention.
  • Avoid alcohol, unreviewed sedatives and combining doxepin products without explicit review. Enzyme-blocking medicines may require lower capsule doses and blood-level checks; cimetidine limits Silenor to 3 mg daily. Liver disease, older age, heart disease, seizures, bipolar disorder and falls need assessment. Severe sleep apnea makes Silenor ordinarily unsuitable.
  • Capsules should be reduced gradually; brief Silenor studies did not show the same withdrawal syndrome. Monitor mood, alertness and bowel/bladder symptoms. Discuss pregnancy; both selected labels advise against breastfeeding because infant sedation and breathing suppression can be serious. Pediatric use is not established.

Urgent help and crisis support · Emergency & Crisis Resources (US)

What can help day to day?

  • The product and dose change the purpose of treatment. A capsule prescribed for depression is not a substitute for a 3- or 6-mg Silenor tablet.
  • Silenor’s meal restriction is distinctive: taking it within three hours of food can increase next-day effects.
  • The antidepressant capsule has a boxed suicidality warning; Silenor does not carry that box, but still has warnings about mood changes and dangerous sleep behavior.

How does it work?

Doxepin has effects that depend on the product and the amount used. Its antidepressant mechanism is not well understood. The low-dose tablet may help people stay asleep by blocking the response to histamine, a chemical messenger involved in wakefulness. These are related uses of the same molecule, but understanding one effect does not make the different products interchangeable.

Explore medication science

How was this medicine developed?

Sinequan capsules received FDA approval in 1969. Silenor was approved in 2010 for sleep-maintenance insomnia at much lower doses. This later product expanded the use of the ingredient without making the two formulations interchangeable.

How do I say the name?

Doxepin: DOX-eh-pin. Capital letters show the stressed syllable.

Medicine forms and official information

Match the full name, release type and route on your prescription. Different formulations need their own prescribing instructions; do not switch or substitute them yourself.

Sources and References

Sources support the U.S. products described here. Product instructions can differ; use the information supplied with your own medicine.

  1. Doxepin: current prescribing information
  2. Doxepin: FDA approval history
  3. Doxepin: patient medicine information
  4. Silenor: current prescribing information
  5. Silenor: FDA approval history
  6. Doxepin: Package Insert / Prescribing Information / MOA
  7. Doxepin: FDA prescribing information
  8. Silenor: Package Insert / Prescribing Information / MOA
  9. Amitriptyline: prescribing information
  10. Silenor: FDA prescribing information
  11. Doxepin for insomnia: patient information
  12. Doxepin: verified neutral parent, PubChem CID 3158
  13. What Is a Neurotransmitter? — mechanism explanation

    Scope: Mechanism explanation only. Source sections checked: How Neurotransmitters Work; Types of Neurotransmitters..

  14. ISMP List of Confused Drug Names
  15. Frequently Asked Questions about Labeling for Prescription Medicines | FDA
  16. Serotonin syndrome: MedlinePlus Medical Encyclopedia
  17. Monitoring a person during and after antidepressant switching – NHS SPS - Specialist Pharmacy Service – The first stop for professional medicines advice

Giving medicine safely to children: family guide (PDF, 3 pages)

How information is checked

Was this article helpful?

Was this article helpful?

Sends your choice, article identifier, edition and optional issue to Psychiatry Atlas. No name, email or medical details are requested. Daily network codes help prevent spam; hosting may process technical information. This is not a promise of anonymity. Privacy details.

Enable JavaScript to send feedback.

Suggest a missing topic or describe a correction. Please keep personal medical information out of website feedback.

Back to top